Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

NCT00559988 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2718

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter
Stroke
Embolism, Systemic Arterial
Major Bleeding

Interventions

DRUG: Home Monitoring Guided OAC
DRUG: Physician-Directed OAC

Sponsor

Biotronik, Inc.